Results
eNauka >
Rezultati >
CYP2C19 slow metabolizer phenotype is associated with lower antidepressant efficacy and tolerability: clinical study on 102 inpatients
| Naziv: | CYP2C19 slow metabolizer phenotype is associated with lower antidepressant efficacy and tolerability: clinical study on 102 inpatients | Autori: | Joković, Danilo; Milosavljević, Filip |
Godina: | 2022 | Publikacija: | Neuroscience Applied | ISSN: | 2772-4085![]() Pretraži identifikator |
Izdavač: | Elsevier | Tip rezultata: | Konferencijski rad | Kolacija: | vol. 1 br. (P.01114) str. 100217-100217 | DOI: | 10.1016/j.nsa.2022.100217 | URI: | https://enauka.gov.rs/handle/123456789/758859 https://farfar.pharmacy.bg.ac.rs/handle/123456789/4730 |
M-kategorija: | Mp kategorija će biti prikazana naknadno. |
